Acute Myeloid Leukemia

This book provides a comprehensive overview of acute myeloid leukemia (AML), covering epidemiology, etiology, diagnosis, treatment, and drug development. It is written by a team of leading experts and is a valuable resource for clinicians and researchers.

Format: Paperback / softback
Length: 358 pages
Publication date: 20 May 2022
Publisher: Springer Nature Switzerland AG

This comprehensive book, penned by a team of esteemed experts, offers a thorough exploration of acute myeloid leukemia (AML), the most prevalent acute leukemia among adults. The initial chapters provide a current overview of AML's epidemiology, etiological factors, and pathogenesis, as well as its molecular development. Detailed guidance is provided on conducting laboratory and clinical diagnostic workup, disease classification, and identifying patient- and disease-related factors that influence prognosis and treatment allocation.

Based on these overarching considerations, initial treatments for patients deemed fit for intensive treatment, as well as older and co-morbid patients, are reviewed. The available relapse treatment strategies are explained, and the most recent data on the optimal use of newly approved agents in different AML subgroups are presented.

Separate chapters delve into the treatment of acute promyelocytic leukemia, current practices of allogeneic stem cell transplantation, and special clinical situations. Finally, promising approaches in drug development, current standards and challenges in assessing measurable residual disease, immune approaches, and ideas for innovative trial designs are considered.

This invaluable resource is a must-read for healthcare professionals, researchers, and individuals seeking to gain a deeper understanding of AML and its treatment. It serves as a valuable tool in improving patient outcomes and advancing the field of leukemia research.

Weight: 699g
Dimension: 254 x 178 (mm)
ISBN-13: 9783030726782
Edition number: 1st ed. 2021